{"i": ["neoadjuvant chemotherapy .", "CEA", "CEA , CA19 - 9 and CA72 - 4 )", "carcino - embryonic antigen ( CEA ), carbohydrate antigen 19 - 9 ( CA19 - 9 ), carbohydrate antigen 72 - 4", "CEA , CA19 - 9 , CA72 - 4", "CEA , CA19 - 9 and CA72 - 4", "AFP , CEA , CA125 and CA19 - 9"], "o": ["median survival time ( MST )", "AUC", "survival difference", "GC", "survivals", "shorter survival", "overall positive rate", "Risk score", "risk score", "overall survival .", "GC survival", "CA19 - 9", "Tumor markers", "serum expression levels", "expression level of tumor maker", "Serum expression levels of three tumor markers", "cancer specific survival ( CSS )", "survival", "expression level", "AUCs", "lymph node involvement", "cancer - related death .", "5 - year overall survival", "Risk score and the 7th AJCC stage", "MST", "HR", "serum expression levels of tumor marker ( CEA , CA19 - 9 and CA72 - 4 )", "serum expression levels of tumor markers ( CEA , CA19 - 9 and CA72 - 4", "pre - therapeutic level of CEA", "depth of wall invasion , lymph node metastasis , remote metastasis", "relapse", "tumor markers", "CSS"]}